ResourcesVendorsDICOMDICOM Interface Components & SoftwareFlux IncToronto, OneMail:Website:https://fluxinc.caLatest from Flux IncClinical NewsDutch isotope reactor restartsBy AuntMinnieEurope.com staff writersThe High Flux Reactor (HFR) in Petten, the Netherlands, has restarted after a forced shutdown due to a water leak in January, with isotopes deliveries to hospitals expected within two weeks.March 17, 2022Molecular ImagingAuntMinnieEurope.com Molecular Imaging InsiderBy Will MortonFebruary 15, 2022SocioeconomicCrisis over? Global isotope supply begins to return to normalBy Will MortonThe European nuclear medicine industry's efforts to ensure adequate supply of essential isotopes seem to be paying off. Serious shortages of molybdenum-99 and iodine-131 have been averted, leading expert Erich Kollegger reveals in an exclusive interview.February 15, 2022Industry NewsIsotope shortage expected to last weeksBy AuntMinnieEurope.com staff writersShortages of global supplies of molybdenum-99 and lutetium-177 may be inevitable until approximately mid-February due to a recent shutdown of a nuclear reactor in Petten, the Netherlands, according to Nuclear Medicine Europe.February 3, 2022Industry NewsPolish nuclear reactor fills gap caused by Dutch reactor faultBy AuntMinnieEurope.com staff writersThe Maria nuclear reactor in Poland filled the gap in medical molybdenum-99 production caused by a fault discovered in the Dutch Petten High Flux Reactor reactor.January 30, 2022Industry NewsShutdown of Dutch reactor poses threat to isotope suppliesBy Will MortonEurope's nuclear medicine agency has warned that the closure of a nuclear reactor in Petten, the Netherlands, will have a serious impact on global supplies of molybdenum-99 and lutetium-177 for medical use in the weeks ahead.January 27, 2022Clinical NewsShine names VP of European operationsBy AuntMinnieEurope.com staff writersMedical isotope firm Shine Medical Technologies has appointed Harrie Buurlage as vice president (VP) of European operations.September 3, 2019Clinical NewsDutch to develop new radiopharmaceuticalsBy AuntMinnieEurope.com staff writersThe Dutch organization Kansen voor West (Opportunities for the West) has awarded a subsidy of 6.8 million euros to the Advancing Nuclear Medicine consortium to develop new radiopharmaceuticals to advance nuclear medicine.January 22, 2019Clinical NewsMolybdenum-99 shortage may soon easeBy AuntMinnieEurope.com staff writersGlobal supplies of the key radiopharmaceutical molybdenum-99 are expected to improve in the next few weeks, now that two nuclear reactors are back online.November 13, 2018Industry NewsPallas takes design proposals for reactorBy AuntMinnieEurope.com staff writersPlans to replace the existing High Flux Reactor in Petten, the Netherlands are moving forward.August 18, 2015Clinical NewsNRG postpones HFR reactor restartBy AuntMinnieEurope.com staff writersRadiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) on November 30 announced that it has postponed the restart of its High Flux Reactor (HFR) in Petten, the Netherlands, after it discovered an abnormality in the cooling water system of the reactor.December 5, 2012Clinical NewsNRG targets Sept. 9 HFR restartBy AuntMinnieEurope.com staff writersRadiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) said its High Flux Reactor (HFR) in Petten, the Netherlands, is on schedule to achieve full power on September 9.August 25, 2010Clinical NewsDutch regulators OK Petten restartBy AuntMinnieEurope.com staff writersRadiopharmaceutical producer Nuclear Research and Consultancy Group has received approval from Dutch regulators to resume service at its High Flux Reactor in Petten, the Netherlands.July 20, 2010Clinical NewsCzechs, Belgians partner on isotopesBy AuntMinnieEurope.com staff writersThe Czech Institute of Nuclear Medicine (UJV) will partner with the Belgian Institute for Radioelements (IRE) to produce radioisotopes.May 19, 2010Clinical NewsSNM warns of 'significant disruptions' in Mo-99 supplyBy Wayne ForrestWith a confluence of nuclear reactor shutdowns around the world this week, SNM is warning nuclear medicine practitioners to brace for the "one of the most significant disruptions ever in the supply of molybdenum-99" (Mo-99) from March 21 to April 11.March 21, 2010
